These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. In vitro analysis of resistance selection by linezolid in vancomycin-susceptible and -resistant Enterococcus faecalis and Enterococcus faecium. Allen GP, Bierman BC. Int J Antimicrob Agents; 2009 Jul 01; 34(1):21-4. PubMed ID: 19243921 [Abstract] [Full Text] [Related]
15. Experience with linezolid therapy in children with osteoarticular infections. Chen CJ, Chiu CH, Lin TY, Lee ZL, Yang WE, Huang YC. Pediatr Infect Dis J; 2007 Nov 01; 26(11):985-8. PubMed ID: 17984803 [Abstract] [Full Text] [Related]
16. Short-term success, but long-term treatment failure with linezolid for enterococcal endocarditis. Berdal JE, Eskesen A. Scand J Infect Dis; 2008 Nov 01; 40(9):765-6. PubMed ID: 18609208 [Abstract] [Full Text] [Related]
18. Impact of linezolid on economic outcomes and determinants of cost in a clinical trial evaluating patients with MRSA complicated skin and soft-tissue infections. McKinnon PS, Sorensen SV, Liu LZ, Itani KM. Ann Pharmacother; 2006 Jun 01; 40(6):1017-23. PubMed ID: 16720705 [Abstract] [Full Text] [Related]